Company Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops a platform for cell engineering in the United States.
It operates through the Cell Engineering and Biosecurity segments. The company offers cell engineering research and development solutions, as well as cell engineering tools comprising functional genomics, antibody developability, and small molecule developability, artificial intelligence models, and reconfigurable automation cart systems on its platform for use in the research, development, and commercialization of engineered organisms and derived products.
It also provides biomonitoring and bioinformatics support services through Canopy, which generates genomic data from strategically positioned nodes through biomonitoring programs; and Horizon, a digital surveillance, analytics, and insights platform that detects and monitors biothreats.
In addition, the company offers genetic medicine R&D, protein engineering, bioprocess development, crop nutrition and protection solutions, and plant trait optimization.
The company serves pharmaceutical and biotechnology, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries.
Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
| Country | United States |
| Founded | 2008 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 485 |
| CEO | Jason Kelly |
Contact Details
Address: 27 Drydock Avenue, 8th Floor Boston, Massachusetts 02210 United States | |
| Phone | 877 422 5362 |
| Website | ginkgo.bio |
Stock Details
| Ticker Symbol | DNA |
| Exchange | NYSE |
| Stock Type | Common Stock |
| Share Class | Class A Shares |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 1830214 |
| CUSIP Number | 37611X209 |
| ISIN Number | US37611X2099 |
| Employer ID | 87-2652913 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Dr. Jason Kelly Ph.D. | Co-Founder, Co-Chief Operating Officer, Chief Executive Officer and Director |
| Dr. Reshma P. Shetty | Co-Founder, President, Chief Operating Officer Director |
| Thomas Knight Jr. | Founder |
| Austin Che Ph.D. | Co-Founder and Head of Strategy |
| Bartholomew Canton Ph.D. | Co-Founder and Chief Technology Officer |
| Steven P. Coen CPA | Chief Financial Officer |
| Jennifer Wipf | Co-Chief Operating Officer |
| Karen Tepichin | General Counsel and Secretary |
| Daniel Marshall | Senior Manager of Communications and Ownership |
| Samantha Sutton | Head of People |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 16, 2026 | 144 | Filing |
| Mar 11, 2026 | 144 | Filing |
| Feb 27, 2026 | 8-K | Current Report |
| Feb 26, 2026 | S-8 | Securities to be offered to employees in employee benefit plans |
| Feb 26, 2026 | 10-K | Annual Report |
| Feb 26, 2026 | 8-K | Current Report |
| Feb 5, 2026 | SCHEDULE 13G/A | Filing |
| Feb 4, 2026 | 144 | Filing |
| Jan 20, 2026 | 144 | Filing |
| Jan 7, 2026 | 144 | Filing |